Copernicus Therapeutics is a privately held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Western Reserve University that provide the foundation for the use of DNA as drugs. The company focuses on using its technologies to make and sell gene therapy products to treat, cure or prevent human diseases. It intends to become a leading biopharmaceutical company by utilizing its DNA nanoparticle technologies to produce safe and effective DNA drugs. To maximize shareholder value, the company is using its expertise in lung gene transfer by developing products for the cystic fibrosis market. Its second therapeutic product will be for treating hemophilia B. Copernicus Therapeutics is headquartered in Cleveland.

Website: cgsys.com

Phone: (216) 231-0227